Industry Research Reports
Home > Reports > Service & Software > Global Viral Inactivation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Viral Inactivation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Service & Software
Published Date: 2025-09-06
Pages: 91 Pages
Report ld: 4999537
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Viral Inactivation Market Size(US$)
CAGR 2025-2031
10.1%
Market Size,2031
USD 1,177
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 662 million
Market Forecast in 2031(Value)
US$ 1,177 million
CAGR
10.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Viral Inactivation market size was US$ 607 million in 2024 and is forecast to a readjusted size of US$ 1177 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Estimates of their viral inactivation market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
The global Viral Inactivation market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Danaher
- Merck
- Parker Hannifin
- Sartorius
- SGS
- Charles River Laboratories International
- Clean Cells
- Rad Source Technologies
- Texcell
- Viral Inactivated Plasma Systems
- Wuxi Pharmatech (Cayman)
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Kits and Reagents
- Services
- Viral Inactivation Systems and Accessories
Segment by Application
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Stem Cell Products
- Tissue and Tissue Products
- Vaccines and Therapeutics
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Viral Inactivation market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Services in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cellular and Gene Therapy Products in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Viral Inactivation value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Kits and Reagents
1.2.3 Services
1.2.4 Viral Inactivation Systems and Accessories
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Blood and Blood Products
1.3.3 Cellular and Gene Therapy Products
1.3.4 Stem Cell Products
1.3.5 Tissue and Tissue Products
1.3.6 Vaccines and Therapeutics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Inactivation Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Viral Inactivation Revenue Market Share by Region (2020-2025)
2.4 Global Viral Inactivation Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Viral Inactivation Market Size and Prospective (2020-2031)
2.5.2 Europe Viral Inactivation Market Size and Prospective (2020-2031)
2.5.3 China Viral Inactivation Market Size and Prospective (2020-2031)
2.5.4 Japan Viral Inactivation Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Viral Inactivation Market Size and Prospective (2020-2031)
2.5.6 India Viral Inactivation Market Size and Prospective (2020-2031)
2.5.7 Central & South America Viral Inactivation Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Viral Inactivation Historic Market Size by Type (2020-2025)
3.2 Global Viral Inactivation Forecasted Market Size by Type (2026-2031)
3.3 Different Types Viral Inactivation Representative Players
4 Breakdown Data by Application
4.1 Global Viral Inactivation Historic Market Size by Application (2020-2025)
4.2 Global Viral Inactivation Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Viral Inactivation Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Viral Inactivation Players by Revenue (2020-2025)
5.1.2 Global Viral Inactivation Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Viral Inactivation Revenue
5.4 Global Viral Inactivation Market Concentration Analysis
5.4.1 Global Viral Inactivation Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Viral Inactivation Revenue in 2024
5.5 Global Key Players of Viral Inactivation Head office and Area Served
5.6 Global Key Players of Viral Inactivation, Product and Application
5.7 Global Key Players of Viral Inactivation, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Viral Inactivation Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Viral Inactivation Market Size by Type (2020-2025)
6.1.2.2 North America Viral Inactivation Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Viral Inactivation Market Size by Application (2020-2025)
6.1.3.2 North America Viral Inactivation Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Viral Inactivation Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Viral Inactivation Market Size by Type (2020-2025)
6.2.2.2 Europe Viral Inactivation Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Viral Inactivation Market Size by Application (2020-2025)
6.2.3.2 Europe Viral Inactivation Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Viral Inactivation Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Viral Inactivation Market Size by Type (2020-2025)
6.3.2.2 China Viral Inactivation Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Viral Inactivation Market Size by Application (2020-2025)
6.3.3.2 China Viral Inactivation Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Viral Inactivation Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Viral Inactivation Market Size by Type (2020-2025)
6.4.2.2 Japan Viral Inactivation Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Viral Inactivation Market Size by Application (2020-2025)
6.4.3.2 Japan Viral Inactivation Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Viral Inactivation Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Viral Inactivation Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Viral Inactivation Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Viral Inactivation Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Viral Inactivation Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Viral Inactivation Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Viral Inactivation Market Size by Type (2020-2025)
6.6.2.2 India Viral Inactivation Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Viral Inactivation Market Size by Application (2020-2025)
6.6.3.2 India Viral Inactivation Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Danaher
7.1.1 Danaher Company Details
7.1.2 Danaher Business Overview
7.1.3 Danaher Viral Inactivation Introduction
7.1.4 Danaher Revenue in Viral Inactivation Business (2020-2025)
7.1.5 Danaher Recent Development
7.2 Merck
7.2.1 Merck Company Details
7.2.2 Merck Business Overview
7.2.3 Merck Viral Inactivation Introduction
7.2.4 Merck Revenue in Viral Inactivation Business (2020-2025)
7.2.5 Merck Recent Development
7.3 Parker Hannifin
7.3.1 Parker Hannifin Company Details
7.3.2 Parker Hannifin Business Overview
7.3.3 Parker Hannifin Viral Inactivation Introduction
7.3.4 Parker Hannifin Revenue in Viral Inactivation Business (2020-2025)
7.3.5 Parker Hannifin Recent Development
7.4 Sartorius
7.4.1 Sartorius Company Details
7.4.2 Sartorius Business Overview
7.4.3 Sartorius Viral Inactivation Introduction
7.4.4 Sartorius Revenue in Viral Inactivation Business (2020-2025)
7.4.5 Sartorius Recent Development
7.5 SGS
7.5.1 SGS Company Details
7.5.2 SGS Business Overview
7.5.3 SGS Viral Inactivation Introduction
7.5.4 SGS Revenue in Viral Inactivation Business (2020-2025)
7.5.5 SGS Recent Development
7.6 Charles River Laboratories International
7.6.1 Charles River Laboratories International Company Details
7.6.2 Charles River Laboratories International Business Overview
7.6.3 Charles River Laboratories International Viral Inactivation Introduction
7.6.4 Charles River Laboratories International Revenue in Viral Inactivation Business (2020-2025)
7.6.5 Charles River Laboratories International Recent Development
7.7 Clean Cells
7.7.1 Clean Cells Company Details
7.7.2 Clean Cells Business Overview
7.7.3 Clean Cells Viral Inactivation Introduction
7.7.4 Clean Cells Revenue in Viral Inactivation Business (2020-2025)
7.7.5 Clean Cells Recent Development
7.8 Rad Source Technologies
7.8.1 Rad Source Technologies Company Details
7.8.2 Rad Source Technologies Business Overview
7.8.3 Rad Source Technologies Viral Inactivation Introduction
7.8.4 Rad Source Technologies Revenue in Viral Inactivation Business (2020-2025)
7.8.5 Rad Source Technologies Recent Development
7.9 Texcell
7.9.1 Texcell Company Details
7.9.2 Texcell Business Overview
7.9.3 Texcell Viral Inactivation Introduction
7.9.4 Texcell Revenue in Viral Inactivation Business (2020-2025)
7.9.5 Texcell Recent Development
7.10 Viral Inactivated Plasma Systems
7.10.1 Viral Inactivated Plasma Systems Company Details
7.10.2 Viral Inactivated Plasma Systems Business Overview
7.10.3 Viral Inactivated Plasma Systems Viral Inactivation Introduction
7.10.4 Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2020-2025)
7.10.5 Viral Inactivated Plasma Systems Recent Development
7.11 Wuxi Pharmatech (Cayman)
7.11.1 Wuxi Pharmatech (Cayman) Company Details
7.11.2 Wuxi Pharmatech (Cayman) Business Overview
7.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Introduction
7.11.4 Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2020-2025)
7.11.5 Wuxi Pharmatech (Cayman) Recent Development
8 Viral Inactivation Market Dynamics
8.1 Viral Inactivation Industry Trends
8.2 Viral Inactivation Market Drivers
8.3 Viral Inactivation Market Challenges
8.4 Viral Inactivation Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Viral Inactivation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Viral Inactivation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Viral Inactivation Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Viral Inactivation Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Viral Inactivation Revenue Share by Region (2020-2025)
Table 6. Global Viral Inactivation Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Viral Inactivation Revenue Share Forecast by Region (2026-2031)
Table 8. Global Viral Inactivation Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Viral Inactivation Revenue Market Share by Type (2020-2025)
Table 10. Global Viral Inactivation Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Viral Inactivation Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Viral Inactivation Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Viral Inactivation Revenue Market Share by Application (2020-2025)
Table 15. Global Viral Inactivation Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Viral Inactivation Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Viral Inactivation Application
Table 18. Global Viral Inactivation Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Viral Inactivation Market Share by Players (2020-2025)
Table 20. Global Top Viral Inactivation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2024)
Table 21. Ranking of Global Top Viral Inactivation Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Viral Inactivation Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Viral Inactivation, Headquarters and Area Served
Table 24. Global Key Players of Viral Inactivation, Product and Application
Table 25. Global Key Players of Viral Inactivation, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Viral Inactivation Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Viral Inactivation Revenue Market Share by Company (2020-2025)
Table 29. North America Viral Inactivation Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Viral Inactivation Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Viral Inactivation Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Viral Inactivation Revenue Market Share by Company (2020-2025)
Table 33. Europe Viral Inactivation Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Viral Inactivation Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Viral Inactivation Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Viral Inactivation Revenue Market Share by Company (2020-2025)
Table 37. China Viral Inactivation Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Viral Inactivation Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Viral Inactivation Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Viral Inactivation Revenue Market Share by Company (2020-2025)
Table 41. Japan Viral Inactivation Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Viral Inactivation Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Viral Inactivation Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Viral Inactivation Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Viral Inactivation Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Viral Inactivation Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Viral Inactivation Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Viral Inactivation Revenue Market Share by Company (2020-2025)
Table 49. India Viral Inactivation Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Viral Inactivation Market Size by Application (2020-2025) & (US$ Million)
Table 51. Danaher Company Details
Table 52. Danaher Business Overview
Table 53. Danaher Viral Inactivation Product
Table 54. Danaher Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 55. Danaher Recent Development
Table 56. Merck Company Details
Table 57. Merck Business Overview
Table 58. Merck Viral Inactivation Product
Table 59. Merck Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 60. Merck Recent Development
Table 61. Parker Hannifin Company Details
Table 62. Parker Hannifin Business Overview
Table 63. Parker Hannifin Viral Inactivation Product
Table 64. Parker Hannifin Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 65. Parker Hannifin Recent Development
Table 66. Sartorius Company Details
Table 67. Sartorius Business Overview
Table 68. Sartorius Viral Inactivation Product
Table 69. Sartorius Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 70. Sartorius Recent Development
Table 71. SGS Company Details
Table 72. SGS Business Overview
Table 73. SGS Viral Inactivation Product
Table 74. SGS Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 75. SGS Recent Development
Table 76. Charles River Laboratories International Company Details
Table 77. Charles River Laboratories International Business Overview
Table 78. Charles River Laboratories International Viral Inactivation Product
Table 79. Charles River Laboratories International Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 80. Charles River Laboratories International Recent Development
Table 81. Clean Cells Company Details
Table 82. Clean Cells Business Overview
Table 83. Clean Cells Viral Inactivation Product
Table 84. Clean Cells Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 85. Clean Cells Recent Development
Table 86. Rad Source Technologies Company Details
Table 87. Rad Source Technologies Business Overview
Table 88. Rad Source Technologies Viral Inactivation Product
Table 89. Rad Source Technologies Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 90. Rad Source Technologies Recent Development
Table 91. Texcell Company Details
Table 92. Texcell Business Overview
Table 93. Texcell Viral Inactivation Product
Table 94. Texcell Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 95. Texcell Recent Development
Table 96. Viral Inactivated Plasma Systems Company Details
Table 97. Viral Inactivated Plasma Systems Business Overview
Table 98. Viral Inactivated Plasma Systems Viral Inactivation Product
Table 99. Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 100. Viral Inactivated Plasma Systems Recent Development
Table 101. Wuxi Pharmatech (Cayman) Company Details
Table 102. Wuxi Pharmatech (Cayman) Business Overview
Table 103. Wuxi Pharmatech (Cayman) Viral Inactivation Product
Table 104. Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2020-2025) & (US$ Million)
Table 105. Wuxi Pharmatech (Cayman) Recent Development
Table 106. Viral Inactivation Market Trends
Table 107. Viral Inactivation Market Drivers
Table 108. Viral Inactivation Market Challenges
Table 109. Viral Inactivation Market Restraints
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Viral Inactivation Product Picture
Figure 2. Global Viral Inactivation Market Share by Type: 2024 VS 2031
Figure 3. Kits and Reagents Features
Figure 4. Services Features
Figure 5. Viral Inactivation Systems and Accessories Features
Figure 6. Global Viral Inactivation Market Share by Application: 2024 VS 2031
Figure 7. Blood and Blood Products
Figure 8. Cellular and Gene Therapy Products
Figure 9. Stem Cell Products
Figure 10. Tissue and Tissue Products
Figure 11. Vaccines and Therapeutics
Figure 12. Viral Inactivation Report Years Considered
Figure 13. Global Viral Inactivation Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Viral Inactivation Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Viral Inactivation Revenue Market Share by Region: 2020 VS 2024
Figure 16. North America Viral Inactivation Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Europe Viral Inactivation Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. China Viral Inactivation Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Japan Viral Inactivation Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Southeast Asia Viral Inactivation Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. India Viral Inactivation Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Central & South America Viral Inactivation Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Global Viral Inactivation Market Share by Players in 2024
Figure 24. Global Top Viral Inactivation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2024)
Figure 25. The Top 10 and 5 Players Market Share by Viral Inactivation Revenue in 2024
Figure 26. North America Viral Inactivation Market Share by Type (2020-2025)
Figure 27. North America Viral Inactivation Market Share by Application (2020-2025)
Figure 28. Europe Viral Inactivation Market Share by Type (2020-2025)
Figure 29. Europe Viral Inactivation Market Share by Application (2020-2025)
Figure 30. China Viral Inactivation Market Share by Type (2020-2025)
Figure 31. China Viral Inactivation Market Share by Application (2020-2025)
Figure 32. Japan Viral Inactivation Market Share by Type (2020-2025)
Figure 33. Japan Viral Inactivation Market Share by Application (2020-2025)
Figure 34. Southeast Asia Viral Inactivation Market Share by Type (2020-2025)
Figure 35. Southeast Asia Viral Inactivation Market Share by Application (2020-2025)
Figure 36. India Viral Inactivation Market Share by Type (2020-2025)
Figure 37. India Viral Inactivation Market Share by Application (2020-2025)
Figure 38. Danaher Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 39. Merck Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 40. Parker Hannifin Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 41. Sartorius Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 42. SGS Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 43. Charles River Laboratories International Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 44. Clean Cells Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 45. Rad Source Technologies Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 46. Texcell Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 47. Viral Inactivated Plasma Systems Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 48. Wuxi Pharmatech (Cayman) Revenue Growth Rate in Viral Inactivation Business (2020-2025)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 10.1% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
Which companies rank high in the global Viral Inactivation market?
What was the global market size of Viral Inactivation in 2031?
What was the global market size of Viral Inactivation in 2025?
What is the annual compound growth rate of the global Viral Inactivation market size from 2025 to 2031?
Related Reports
Viral Inactivation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Viral Inactivation was estimated to be worth US$ 662 million in 2025 and is projected to reach US$ 1283 million, growing at a CAGR of 10.1% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 120
USD 3950.00
(Single User License)
Global Viral Inactivation Market Research Report 2026
The global Viral Inactivation market was valued at US$ 662 million in 2025 and is anticipated to reach US$ 1283 million by 2032, at a CAGR of 10.1% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 117
USD 2900.00
(Single User License)
Global Viral Inactivation Market Research Report 2025
The global market for Viral Inactivation was valued at US$ 607 million in the year 2024 and is projected to reach a revised size of US$ 1177 million by 2031, growing at a CAGR of 10.1% during the forecast period.
Published Date: 2025-02-27
Pages: 83
USD 2900.00
(Single User License)
Viral Inactivation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Viral Inactivation was estimated to be worth US$ 607 million in 2024 and is forecast to a readjusted size of US$ 1177 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 112
USD 3950.00
(Single User License)
Global Viral Inactivation Market Insights, Forecast to 2030
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published Date: 2024-04-25
Pages: 106
USD 4900.00
(Single User License)
Global Viral Inactivation Market Research Report 2024
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published Date: 2024-01-11
Pages: 84
USD 2900.00
(Single User License)
Viral Inactivation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Viral Inactivation was estimated to be worth US$ 662 million in 2025 and is projected to reach US$ 1283 million, growing at a CAGR of 10.1% from 2026 to 2032.
Published: 2026-07-15
Pages: 120
USD 3950.00 (Single User License)Global Viral Inactivation Market Research Report 2026
The global Viral Inactivation market was valued at US$ 662 million in 2025 and is anticipated to reach US$ 1283 million by 2032, at a CAGR of 10.1% from 2026 to 2032.
Published: 2026-04-28
Pages: 117
USD 2900.00 (Single User License)Global Viral Inactivation Market Research Report 2025
The global market for Viral Inactivation was valued at US$ 607 million in the year 2024 and is projected to reach a revised size of US$ 1177 million by 2031, growing at a CAGR of 10.1% during the forecast period.
Published: 2025-02-27
Pages: 83
USD 2900.00 (Single User License)Viral Inactivation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Viral Inactivation was estimated to be worth US$ 607 million in 2024 and is forecast to a readjusted size of US$ 1177 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 112
USD 3950.00 (Single User License)Global Viral Inactivation Market Insights, Forecast to 2030
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published: 2024-04-25
Pages: 106
USD 4900.00 (Single User License)Global Viral Inactivation Market Research Report 2024
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published: 2024-01-11
Pages: 84
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now